Reddit Posts
I will tell you everything I am invested in, you rate my portfolio. 1 to 5. 5 being awesome....
$ELTP Up Another 10% - Moonshot on Feb 12th Earnings Call?
ELTP - Upcoming Earnings Call and New Prasco Shipments
ELTP ANDA Filing - $5.1 Billion IQVIA Market Value
ELTP -I see so many bad recommendations on here, yet I keep recommending this gem...
ELTP 886% YOY Growth Net Income - Double up SP tomorrow?
886% increase in net income for comparable period of the prior year!!! ELTP is HOT!!!
Penny stocks with promising potential catalysts in 2024: ELTP, BITF, LLAP, and OLB
ELTP...I've been trying to tell you guys for 2 years now...
Why I believe in Elite Pharmaceuticals $ELTP
ELTP UP 39.52% volume 5,317,184 shares traded today!!!
Q4 Stock Predictions: ELTP, OLB, PHX, and GNS are primed to roar into 2024.
ELTP - 93% of money invested in this moon shot
Elite Pharmaceuticals-ELTP New Drug 5.1 Billions IQVIA Market
ELTP - Stock Analysis was spot ON
I'll stop posting ELTP when it stops gaining 20% a day
$ELTP New Financials - Ready to Retire/All-In - Boom time
$ELTP Up 55% from Low - Ready for Breakout?
ELTP Mentioned in Article as Potential Growth Stock
$ELTP Up 30% in last 5 days - 68% in last 6 months
So tell me why companies like this are attacked and abused on the OTC???
Riddle me this - why so abused and attacked on the OTC???
Lets talk about an abused OTC company (ELTP) that is going GLOBAL today!
$ELTP ~ Is this being overlooked or am I missing something?
Mentions
I’m holding ELTP until they’re bought out.
ELTP up slow and steady
ELTP slow and steady back up 3x by end of year if sold!
ELTP......ELITE PHARMACEUTICALS NEW Jersey 90 million a year. 5 year record breaking anual sales. Listing for sale in 3 months. Being prepared as we speak.
Its not mine, its what Goodrx said. Look it up. Also 27 billion is based on the brand pricing. 2 I already explained to you that Mylan won the first to file meaning they are going to blitz the market before any generic. They are not launching until 2028 when the patent expires. Mylan will have exclusivity for another 6 months. ELTP iss not even been approved. They havent even filed. There is a whole more to filing an ANDA than BE study. Also the ceo seems to intentionally mislead by using market penetration as the metrics instead of the revenue. With Liz, they have 18 manufacturers already since 2023 that includes Mylan Hikma Teva Amneal . Like heavyhitters in generics. In few months ELTP is not gonna be taking 10 percent of the market share. Market penetration can mean a lot smaller sub set of the region. In any case it does better what i think or what you think if there is no offers or bidders. Good luck to you
You called me a moron. I didn't call you nothing. Lot pumpers resort to name calling but i ignore that shit cuse i wanna get into the details. What is your evaluation? How much do you think it should be valued at? Amphastr has 236M cash on hand my guy. They hit gross profit of 369M. That makes their debt healthy debt. You talking a lot of unsubstantiated projections. Right now, the most ELTP has made is 85M in revenue and my honest question to you is how much do you truly think they are worth? The good thing is that they are engaged with M&A, not hired just testing the waters but they have zero offers or interest currently. They want to be bought out that much they made it clear. So we can wait to see what M&A say they are worth. I promise no one is paying a billion for them. Period. you can cry and call me names all you want. Good luck to you, but you are going to wait a long time for half current valuation.
You are name calling as well. Don't try and take the high ground. You've made numerous claims with zero facts to support them and have been calling me a pumper. That's name calling. Logic is hard for your kind. 1. Your work in Pharma doesn't seem very valuable if you can't offer NUMBERS. Not just "every exec learned their lesson". That's just a bunch of bogeyman talk. Give me hard numbers. Math isn't hard. 2. Pricing is tough - welcome to business, buddy. Republicans and Democrats are NOT pushing harder on generic pricing at all. This is just factually incorrect. They ARE pushing on Branded drug pricing. When you miss points like this it is one more huge reason to discount ANYTHING you say. Ignorant. 3. $80m in revenue growing at 50% per year, revenue will double up when the Mikah buyback occurs, and all of that is discounting a major new drug approval. That's like saying a company has $10k in revenue after they just signed a guaranteed $300m sales contract. If you don't account for future revenues you are dumber than I thought you were. 4. They are not profitable - thank you for admitting you can't read. The loss is a paper loss as they prep to be bought out. It's been addressed in the earnings calls. You either don't listen or are possibly being paid to say this stuff? Either way - same result. It makes me discount your opinion. 5. Amphastar - They have net debt of like $368 million dollars. I notice you used EBITDA here - convenient to not account for the interest cost on that amount of debt. ELTP has ZERO debt now other than a mortgage note for the building they bought. Here's another thing about that debt - what's the rate going to be on it when the Notes come due and have to be refinanced? That's $30 million a year in interest expense at 8%. You want a respectable discussion? Super simple. Just do a valuation and show me your methodology. I would fully respect an opinion that is half of the valuation I'm doing if you can show me how you got there. Amphastar is your best point you have brought up so far, and that should have 2x ELTP revenue with $368 million more debt. Ironically, you are kind of making my point....thank you =) p.s. - if you do end up doing a valuation or you don't, address my valuation I put up for the insurance/mitigation cost of Anti Opioid Abuse tech. What do you give that as value per share? 25 cent? $1? Somewhere between?
So you resort to name calling because I have different opinion that doesn't align with what you are selling? I am gonna keep it respectfully regardless. First of all, I wasn't comparing Teva to ELTP. You missed the point.The is no comparison between Teva and ELTP. The point was Teva when they acquired Actavis is they overpaid for a generic, a lesson learnt by every pharmaceutical executive. There is no comparison my guy between Teva and ELTP, period. I work in pharmaceutical for 15 years. Moving on, ELTP has about what in revenue? $80M to be generous. They are not profitable. The current valuation is OTC valuation my guy. If it uplift to NASDAQ, it will get slaughtered. ELTP ceo said they are engaged with M&A firm to get the right valuation. Call me when they are done and reality checks in. I am not against you or the company, I am just telling you for the generic drug maker, not profitable and making less than $100M in revenue is not worth a billion or 0.6 billion. I ll give you an example Amphastar pharmaceutical makes over 730M in revenue, profitable 230M EBITDA and is barely valued at 1 billion. and you wanna me to believe that a generic drug maker making less than 100M is 600M. Nah. No one is paying that my guy. Sorry. Good luck pumping it though.
If it’s overvalued then you have calculations? If not, you are a moron. I remember my cousin coming in from Indiana, small town of 25k people. He walked in to a project in Malibu and said, “$8million?!?? This is extremely over valued. My papa paid $18k for our house. You’re never going to sell this for $8 million.” That house sold for $25 million. Lesson? Don’t listen to mouth breathers who don’t offer any supporting evidence. Teva was run by a nepo baby when that deal that you are talking about happened. The new CEO is doing an excellent job of working the debt down for that deal. Speaking of that deal…Teva has what percent more revenue than us? And they are a $16 billion company. I know, you’ll say, “Are you comparing us to a company that does x billion in rev?!” Nope. I don’t have to, because they have 2,000x our debt levels. When all is said and done, ELTP will be a cash machine. How do I know this? I buy cash machines as part of what I do for a living. I love to do deals at .75 and 1.25, but some deals have other benefits and I’ll pay a 10 for them. Some have zero profits and I’m only going in because of someone on the team, the leadership, or I want to be involved in something because of FOMO or wanting to be at the table. Best way to understand what a buyer will pay? Look at comparable sales or multiples, then target buyers who value those numbers and see if you have a niche that one would pay a premium for.
The stock price sank after earnings were announced. It's not uncommon for companies even after good earnings, but that's what happened. I suppose sellers waited a few hours to see if naive investors would buy in and run up the price first. That's basically what happened. At the open on Tuesday ELTP moved up to 0.78 and began the serious plunge around 12pm.
No, you got here just in time. After seeing ELTP go down 25% after earnings you've gotten a glimpse into just how confident investors are in this business.
Anyone know what’s going on with ELTP?
Hi, There is a pennystock that keeps giving (to me). I am long on it since 2012. Yesterday there was a teleconference where they provided the current status of the company. Read the transcript or listen to the Teleconference recording on their site. The company will be bought by year end. The CEO is putting it for sale, they have amazing growth, they are Profitable for 6 years now. The company is Elite Pharmaceuticals. $ELTP. I just posted the transcript on Ihub. I prefer not to paste links in here. Good luck! PS: When I say I made money, I made 2.5Million and going for 6 Million.
Future indices are all up afterhours. Hopefully ELTP surges at opener.
ELTP in one more episode of buy the dip
How the hell is ELTP down today
That's why you have to do a very deep search in penny stocks...i would say 99% of subreddit are bots.. check ELTP that's the only solid penny stock i found. Peace ✌️
I believe in this stock too that's why 70% of my portfolio is ELTP! LETS GO
Posting again: $ELTP crushed earnings today. Up 48% from previous year. $NCNA... buy the dip, it's on sale. Did well on phase 1/2. $SENS .... needs more love. A shame. Diabetes huge market still. $ CTM... oldie and a goodie. Govt contracts/ AI / cybersecurity
Exceeded expectations for me! If it wasn't OTC I'd be retiring tomorrow. ELTP is a great stock to hold on to. Best wishes everyone!
$ELTP crushed earnings today. Up 48% from previous year. $NCNA... buy the dip, it's on sale $SENS .... needs more love $ CTM... oldie and a goodie. Govt contracts/ AI / cybersecurity
View in your timezone: [July 1, 2025, at 11:30 AM EDT][0] [0]: https://timee.io/20250701T1530?tl=%24ELTP%20beat%20searnings%20.%20Up%2048%20percent%20from%20previous%20year.
https://www.stocktitan.net/news/ELTP/elite-pharmaceuticals-inc-reports-financial-results-for-the-fiscal-1xyuldmxtusu.html
ELTP is either going to do amazing or I wasted 2 weeks of my time for marginal returns
Be sure to sprinkle a bit of ELTP on it.
https://preview.redd.it/un8dzjz8gs9f1.jpeg?width=1242&format=pjpg&auto=webp&s=c6b41dd93fd48ed9629d4f4d7fdd4242c19b3c1a Up 31% ytd, and about 350% over 1 year. All in on $ELTP
Make sure you all load up on ELTP!
$ELTP! ;) Hats off to you, sir 🍾
Would you say this is more a short-term investment? There's just so many online dick pill mills with new one's popping up constantly. I think the better play is something like ELTP, which sales generic drugs with an ever expanding array of new drugs in the pipeline as drug paten expires.
I am once again here recommending MVST. I used the dip opportunity to average up. Also, still holding ELTP in anticipation of their earnings on 1st of July
ELTP and I don't know of another one that is even CLOSE to this one. It seems like the safest gains to me. That's why I invested $1 million in to it.
i'm saying vintage in the fact that you have been in this stock since an almost retarded amount of time and I love it. You have high conviction and I certainly do agree with your thesis. I currently take two controlled substances, and they are being kept by the pharmaceutical industry and I see ELTP capitalizing.
Please keep ELTP far away from the pump+dumpers here lmao
You should add ELTP to your list about to report 3X revenues compared to last quarter - June 30th AH. Teleconference July 1st 11:30 AM
Hard to ignore that kind of upside with catalysts stacking up. If even half plays out, $ELTP could seriously run.
Meanwhile ELTP (Elite Pharmaceuticals) is skyrocketing today. Generics of highly addictive meds like Adderall or opioids is where the money's at.
Meanwhile ELTP (Elite Pharmaceuticals) is skyrocketing today. Generics of highly addictive meds like Adderall or opioids is where the money's at.
Meanwhile ELTP (Elite Pharmaceuticals) is skyrocketing today. Generics of highly addictive meds like Adderall or opioids is where the money's at.
Meanwhile ELTP (Elite Pharmaceuticals) is skyrocketing today. Generics of highly addictive meds like Adderall or opioids is where the money's at.
ELTP earnings edging closer. Don't sleep on it with all the oil plays this morning
And we'll both be servicing her other boyfriend when ELTP craters back to .04/share 🤷 I am a believer in this stock. At least insofar as it will hit $2/share. I think 4+ is a little too optimistic
Supposedly ELTP is going to get a big increase on the 30th, you might try that
You are a little late, but you still have tons of upside with ELTP. With the new BE approval, my exit value went from $3.60 to $9.
Rumors are ELTP will get bought out, ceo is trying to sell
That one time I full ported my son's UTMA into ELTP
ELTP !!! 
Adding to my MVST and ELTP positions today. Also, taken a position in RBNE after today's dip
Hope you all picked up some of that ELTP dip
I will probably get downvoted, but it was good to buy this ELTP dip 🤣 (at least for the short term)
Thoughts on $ELTP after that major dump Wednesday. Sickening. Hoping for a bounce back to the good ole 70’s and riding that into earnings.
Yeh I'll join for the fun! Missed out on $MBOT -and $ELTP. This one looks legit.
$CTM, an actual penny stock that has legit govt contracts and makes profit. Keep dripping in! $SENS... DIABETES market $ELTP... Long term, high end generics $OPTT... underwater drones and data collecting buoys
$CTM, an actual penny stock that has legit govt contracts and makes profit. Keep dripping in! $SENS... DIABETES market $ELTP... Long term, high end generics
Haha yea really! Personally I love KULR because I made my first $7k in the market on KULR in November and got out while it was still over $3. Reinvested all that in $ELTP now up another 6 on that with plenty more to come ❤️ I'm gonna buy some more KULR after the split 😂
Nice ELTP dip if anyone's looking to get in
Just checked fintel. ELTP looks awful. Why will it 10-20x?
ELTP actually produces adhd meds, strong balance sheet too
NINE and ELTP racing each other to .80!
Thanks to ELTP, my portfolio is a tiny bit in the green today....
My plays for today: CISO / ELTP / RELI
ELTP is rolling, check it out
I see you are a man of ELTP, my good sir.
ELTP is a no brainer, today news are just the tip of the iceberg :)
Been in penny stocks for a couple of years. Important things I look at are debt ratio, revenues, and whether its something I can understand. While many people make loads of money of speculative stocks with lots of debt or more vague business operations. I like to think of these things as "vital signs" of the stock. Sure somebody with bad vital signs can make a turn around and recover, but if they are not breathing, blood pressure is in the tanks, or their heart rate is in the high 200's, there is usually a reason worth considering before investing. Good example of one I've been watching is WWR. Formerly had uranium operations, though the company has not made any revenue since 2009 as they purse the construction of graphite plant (things needed for batteries/electronic components). They have the rights to what is known as the Coosa Graphite Project, something I think could be very lucrative one day. The thing is, the solvency of the business until things get up and going is a significant concern and the reason their share price is as low as it is. High debt, no revenues, but understandable business. Poor vital signs, not invested but watching closely. ELTP on the other hand is one I am heavily invested in. Increasing revenues, fairly simply business to understand, very low debt. Good vital signs.
ELTP is going to absolutely blow past the moon with this new BE study on a $27 Billion drug. It was already going to go up - this is unexpected nitrous to the system.
MVST and ELTP flying for me today. Made the mistake of jumping into NINE PM
No one mentioning ELTP because its pharma? Earnings call is coming soon and the stock is going up almost every day. Could be a good short swing trade. (Im holding long term and its a big part of my portfolio - I will know in a few months if this was a good idea)
$ELTP All day every day for the next 2 weeks. Record breaking earnings call guaranteed on 7/1. They will also announce Q1 earnings early since they will have the numbers. Those will be record breaking numbers as well. Possibly news of hiring an investment banker for sale of the company.
I'm not touching an OTC stock unless it is $ELTP.
Hoping CPSH resumes its uptrend soon. In the green with ELTP and MVST still
Let's not forget about ELTP with its earnings at the the end of the month
With only 4 stocks, hard to grade, but I'll give it a go. I recommended against SPY given the budget, but not because it's bad. It's fantastic, and I'd still take it over Vanguard and Blackrock's offerings in the same space despite the enormous ground those 2 have made. Solid pick even in fractionals, but it doesn't fit your growth needs or make up for that with dividend accruals. Don't sell it now that you have it, of course, but if the budget is the same for 3-5 years, don't let it dominate your portfolio. NVDA is NVDA. Easy pick to throw money at any time between now and 2035. Only up over time, stock of the decade, no notes. ATOS is an interesting value pick. I definitely think it's a bit undervalued. If you REALLY like them, maybe get 3-28 more shares, and hold for a few years. Even if it's a better value play then I give it credit for, there's better opportunities in pharma over the next year that merit more attention. For sub dollars, ELTP is a gold mine as long as stays under 1.50 (ripe for a buyout in 6-18 months is why), but you need a different brokerage (which you're too new for realistically, but you'll want a better one at some point if you don't flame out) because only the big boys like Schwab and Fidelity will let you take a crack at it. And over in Robinhood land, well, I already recommended PFE. It probably won't stay below 30 but for a year or 2 more. AFRM is....there's really no way to sugarcoat, it's a mistake. Some companies, you don't give a damn that they suck on the consumer end - you're trying to make a buck. Others, them being dookie eventually bites their investors in the ass. Affirm is in the latter camp. They suck, AND there's better BNPL plays if you're high on that specifically. Affirm is capped for the future. Hold it for a year, 2 at the most, then dump it for whatever gains you can lock in. Don't get trapped in this one. If you take nothing else away from this: you're on a fine enough start. A safe bet in SPY, a smart megacap growth play in NVDA, and 2 rolls of the dice, one of those being a penny stock. Until you're proven horribly wrong a shit ton and bevome proof of Dunning-Kruger, try to believe in your gut a little bit. That's how the best investors discover over time what they're good at picking, and the sectors where they don't know shit from apple butter. Side note, I actually forgot to mention in my earlier reply what is probably one of the best stocks you could pick up as a budget investor: ARCC. They're a middleman loan company for businesses that's selective about their clientele, have a very good history, solid fundamentals, a sub-25 dollar stock price, and a jaw dropping 8 percent quarterly dividend. They're a bonkers good stock that won't tank, and should basically be to you for your first 3 or so years what SPY is to seasoned investors with bigger budgets. Ares Capital is a phenomenal way to hold money as a broke boy investor and get some value while you sit on it.
ELTP making its run up to earnings, let’s go!
ELTP Earnings report on the 30th
In a very short answer, when a buyout happens, a company is buying an asset that will produce cash flow, or actual existing cash flows. All investors (technically you too whether you realize it or not) trade cash for those cash flows or assets that generate the cash flows. So, will ELTP be bought out for more thant he current price? Almost guaranteed - which is why I assess value at $3.60 per share. It's the price I would expect an investor to pay for the future cash flows of the drug approvals and the pills manufactured from the new FDA plant approved a few months ago.
Are ELTP shareholders confident that them being bought out will make them more money than Elite Pharmaceuticals forging onward otherwise would have?
Elite Pharmaceutical. $ELTP. Like your suggestion!
I’ll trust 27 years of investment experience vs your anecdotal short term bio combined with veiled references to bogeymen. Years of hype men pushing the stock? You just showed that you’ve done no research on this stock or that you are a troll. I find it hard to see it any other way. There are known paid bashers of this stock who have posted over 60,000 posts over 13 years. You have to be certifiably insane…or a paid basher to post that much on a stock that you own zero shares of while doing said behavior. It reminds you of Enron?! Do you just make things up to sound intelligent? Are you narcissistic? How does this remind you of Enron? Did ELTP change to Mark to Market Accounting? Is ELTP just all of a sudden signing 10 year contracts for sales and pushing all the revenue in to a single quarter? Nooope. So that’s weird if you to say. Did the Pharma market get deregulated? Did the CEO take his eyes off the ball of a Harvard trained sociopath? Did the CFO have his wife in a role that is inappropriate? Is your statement before or after Sarbanes Oxley was enacted? Just stop dude. You don’t need to be that hero that just says something contrarian to meet your desires to save someone and be appreciated. You don’t have to spout an opinion on things you know absolutely zero about. I bought an artichoke tonight - I wouldn’t presume to tell a farmer how to run his business. Congrats on buying a bio stock. You lack the skill set to do a deep dive on DD. And that’s OK. If you want to learn that - go learn it or ask a question. Don’t be a DB.
[ELTP Lambo King Mocks Your Gains!](https://youtube.com/watch?v=GsT_bYXsgQY&si=C2SOFz_jC1CkSzVF)
I'm down voting you simply for posting ignorance. Your criteria falls no where near Due Diligence, or close to an ounce of research about this company..., but instead invoked "trust be bro" I know things 🙄 You work with CEOs? Wow congrats. So if I work for the state, that handles PUC, (all approved projects for people like your CEO buddy) does that make my experience better than your 2nd hand "trust me bro"? NO, it's doesn't. Why? Because your conjectures are all based off of some conflationary evidence. NO seriously, your conjecture is truly ridiculous. Are you really an investor? And really know CEOs? Because if you were all of these things, then you would know who Nasrat Hakim was and which big pharma he came from - to take over ELTP, (which saved it from bankruptcy, paid off all their debt & turned the company around within 10 years). This isn't some flash in the pan, over night pump & dump...., but if you did a single ounce of DD - you would have already known all this.
$ELTP single handedly saving my portfolio
I may be a dumbass but I bought in to the ELTP post yesterday and I'm up 13%, make of that what you will
If ELTP can have 3 years of record breaking consistent growth - then a quarter with Vyvanse revenues should be an easy win. Just IMO.
Parked all my money in ELTP yesterday before the small pop. I suggest you all do the same.